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Abstract
Background: To evaluate the concurrent and discriminant validity of a brief DSM-based structured diagnostic
interview for referred individuals with autism spectrum disorders (ASDs).
Methods: To test concurrent validity, we assessed the structured interview’s agreement in 123 youth with the
expert clinician assessment and the Social Responsiveness Scale (SRS). Discriminant validity was examined using
1563 clinic-referred youth.
Results: The structured diagnostic interview and SRS were highly sensitive indicators of the expert clinician
assessment. Equally strong was the agreement between the structured interview and SRS. We found evidence for
high specificity for the structured interview.
Conclusions: A simplified DSM-based ASD structured diagnostic interview could serve as a useful diagnostic aid in
the assessment of subjects with ASDs in clinical and research settings.
Background
Autism spectrum disorders (ASDs) comprise a group of
neuropsychiatric disorders that include autistic disorder,
Asperger’s disorder, and pervasive developmental disor-
der not otherwise specified (PDD-NOS). They are dis-
tinguished from other psychiatric disorders by the
presence of deficits in reciprocal social behavior, var-
iously accompanied by deficits in communication, and/
or repetitive or stereotyped behaviors. The DSM-III-R
[1] and DSM-IV [2] have operationalized the required
diagnostic criteria necessary for establishing diagnoses
of ASDs based on the presence or absence of a set of
categorical symptoms.
While a thorough evaluation by an expert clinician
who has significant experience in specific diagnoses is
considered the best method of diagnosing complex
conditions such as ASDs, structured diagnostic inter-
views have been developed to help non-expert clinicians
elicit the required information for these diagnoses. The
most widely used structured interview tool for establish-
ing a diagnosis of autism in the research setting is the
Autism Diagnostic Interview-Revised (ADI-R). This
interviewer requires specelized training in order to
administer it, and the training to become proficient in
its administration is expensive and time consuming.
Additionally, the ADI-R takes at least 2 hours to com-
plete making it of limited feasibility in clinical settings
and in large population-based studies.
In contrast to the 93 questions and associated com-
plex algorithms of the ADI-R, the DSM includes only 16
items in its diagnostic criteria for ASDs. Moreover,
because the literature clearly indicates that most indivi-
duals with ASD have other comorbid conditions such as
Attention-Defecit/Hyperactivity Disorder (ADHD) and
mood disorders [3-7] and the ADI-R by itself does not
assess other disorders that are pervasive in this
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tions is necessary and increases the length of time
needed for a full assessment. This situation calls for the
development of simplified instruments to aid in the
assessment of ASDs in clinical and non-clinical settings.
Several attempts have been made to simplify the com-
plexity of the assessment process for youth with ASDs.
One such effort is development of the Social Respon-
siveness Scale (SRS), a paper and pencil instrument that
can be completed by parents or teachers in 15-20 min-
utes. Constantino and colleagues [8,12] demonstrated its
concurrent and discriminant validity as a measure of
ASDs. As part of these efforts, Constantino et al. [8]
compared the SRS with the ADI-R in 61 child psychia-
tric patients. Correlations between SRS scores and ADI-
R algorithm scores for DSM-IV criterion sets were on
the order of 0.7. SRS scores were unrelated to I.Q. and
exhibited inter-rater reliability on the order of 0.8.
Though SRS is a valid quantitative measure of autistic
traits, the instrument lacks the ability to distinguish aut-
ism from the spectrum (Asperger’s disorder and PDD-
NOS) in individuals with ASD [8]. Despite the utility of
the SRS as a screening tool for ASD, there continues to
be a need to have a simplified DSM-based structured
diagnostic interview module to aid in the diagnosis of
individuals with ASD in clinical and research settings.
The main aim of the present study was to evaluate the
concurrent and discriminant validity of a simplified,
relatively brief, structured, diagnostic interview closely
linked to the defining features of ASDs in the DSM (see
Table 1). To examine the concurrent validity of this
instrument, we examined its correspondence with a gold
standard expert clinician’s diagnoses in a large sample of
clinically referred youth with ASDs. In addition, we
examined its correspondence with the SRS because of
the previously documented excellent correspondence
between the SRS and the ADI-R [8]. To examine the
discriminant validity of the DSM-ASD structured diag-
nostic interview, we calculated its specificity comparing
subjects with ASD with those from a large sample of
clinic referred youth with ADHD. We hypothesized that
our DSM-based structured diagnostic interview for
ASDs would have good concurrent and discriminant
validity.
Methods
Participants
ASD subjects were youth, ages 4 to 23 years of age, con-
secutively referred to a specialized program for the
treatment of ASDs at a university-affiliated hospital. The
diagnosis of ASD was established by a comprehensive
psychiatric evaluation conducted by an board-certified
psychiatrist experienced in evaluating ASD (GJ). The
psychiatric diagnostic interview was conducted with the
subject and caretaker (usually parent/s) and incorpo-
rated information from multiple sources when available
(psychiatric records, schools, social services). Based on
this clinical evaluation, all ASD subjects met Diagnostic
and Statistical Manual of Mental Disorders - Fourth
Edition (DSM-IV) diagnostic criteria for autistic disor-
der, Asperger’s disorder, or PDD-NOS.
Psychiatric comparison participants were derived from
consecutive referrals to a pediatric psychopharmacology
program at a major academic center from 1991 to 2008.
Children were referred for psychiatric evaluation and
psychopharmacological intervention for behavioral and
emotional difficulties and not for evaluation of any spe-
cific disorder. There was no selection bias based on
social class or insurance restrictions. We included sub-
jects if they met diagnostic criteria for ADHD on a
structured diagnostic interview (Schedule for Affective
Disorder and Schizophrenia for School-Age Children
Epidemiologic Version [K-SADS-E]) [9]. The status of
ASD in the ADHD control participants was assessed by
the DSM based structured interview for ASD (see
below). The structured diagnostic interview was com-
pleted by highly trained and supervised psychometri-
cians from interviews with the parent, usually the
mother. We computed kappa coefficients of agreement
between these raters and experienced board certified
child and adult psychiatrists and licensed clinical psy-
chologists. Based on 500 assessments, the median kappa
coefficient was 0.98. Kappa coefficients for ADHD was
0.88. Before final diagnostica s s i g n m e n t sw e r em a d e ,
information derived from these interviews was reviewed
blindly by a committee of expert clinicians that included
board certified child and adult psychiatrists and experi-
enced licensed psychologists. We estimated the reliabil-
ity of the diagnostic review process by computing kappa
coefficients of agreement for clinician reviewers. For
these diagnoses, the median reliability between indivi-
dual clinicians and the review committee assigned diag-
noses was 0.87. Kappa coefficients for ADHD was 1.0.
Materials
For each ASD subject, a parent also completed The
Social Responsiveness Scale (SRS)[10] a 65 item rating
scale that measures the severity of autism spectrum
symptoms including elements of reciprocal social beha-
viors (39 items), social use of language (6 items), and
behaviors characteristic of children with autism spec-
trum disorders (20 items). Each item on the scale is
rated on a Likert scale from “0” (never true) to “3”
(almost always true). The psychometric properties of the
SRS have been well established [11-14].
DSM-based structured interview for ASD
To assess ASDs we developed DSM-based diagnostic
criterion into an interview format (see Table 1) using
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Page 2 of 7Table 1 ASD symptoms for the structured interview, DSM-III-R and DSM-IV
ASD structured interview DSM-III-R Autistic Disorder DSM-IV Autistic Disorder (Bold=Asperger’s
Disorder)
A. THESE ARE SOME QUESTIONS ABOUT HOW
YOUR SON/DAUGHTER RELATES TO OTHERS.
A. QUALITATIVE IMPAIRMENT IN RECIPROCAL
SOCIAL INTERACTION
(1). QUALITATIVE IMPAIRMENT IN SOCIAL
INTERACTION
1. Did s/he seem unusually unaware of the
existence or feelings of others?
1. Marked lack of awareness of the existence of
or feelings of others
(d) Lack of social or emotional reciprocity
2. Did s/he not come for comfort even when
hurt, or did s/he seek comfort in an odd way
2. No or abnormal seeking of comfort at times
of distress
3. Was s/he unable to imitate others when
appropriate?
3. No or impaired imitation
4. Does s/he have difficulty playing
cooperatively with other children?
4. No or abnormal social play (c) A lack of spontaneous seeking to share
enjoyment, interests, or achievements with
other people
5. Is s/he uninterested in making peer
friendships? Or if s/he is interested, does s/he
seem to understand the conventions of social
interaction?
5. Gross impairment in ability to make peer
friendships
(b) Failure to develop peer relationships
appropriate to developmental level
B. THESE ARE SOME QUESTIONS ABOUT HOW
YOUR SON/DAUGHTER COMMUNICATES OR
PLAYS WITH OTHERS.
B. QUALITATIVE IMPAIRMENT IN VERBAL AND
NONVERBAL COMMUNICATION, AND IN
IMAGINATIVE ACTIVITY
(2). QUALITATIVE IMPAIRMENTS IN
COMMUNICATION
1. Is s/he unable to communicate? 1. No mode of communication, such as
communicative babbling, facial expression,
gesture, mime, or spoken language
(a) Delay in, or total lack of, the development of
spoken language (not accompanied by an
attempt to compensate through alternative
modes of communication such as gesture or
mime)
2. Does s/he avoid looking at people or avoid
greeting people? If no, ask: Does s/he ignore
people around her/him, dislike being held?
2. Markedly abnormal nonverbal communication,
as in the use of eye-to-eye gaze, facial
expression, body posture, or gestures to initiate
or modulate social interaction
(1) (a) Marked impairment in the use of
multiple nonverbal behaviors such as eye-
to-eye gaze, facial expression, body
postures, and gestures to regulate social
interaction
3. Is s/he uninterested in imaginative activities
or stories?
3. Absence of imaginative activity, such as
playacting of adult roles, fantasy characters, or
animals; lack of interest in stories about
imaginary events
(d) Lack of varied, spontaneous make-believe
play or social imitative play appropriate to
developmental level
4. When s/he speaks does her/his tone seem
odd?
4, Marked abnormalities in the production of
speech, including volume, pitch, stress, rate,
rhythm, and intonation
5. Did s/he repeat words or phrases s/he has
just heard, in place of responding to what was
said? Did s/he often use the wrong pronouns
to refer to her/himself or others, or refer to
him/herself in the third person, as “he wants a
remarks cracker?”
5. Marked abnormalities in the form or content
of speech, including stereotyped and repetitive
use of speech; use of “you” when “I” is meant;
idiosyncratic use of words or phrases; or
frequent irrelevant remarks
(c) Stereotyped and repetitive use of language
or idiosyncratic language
6. Did s/he seldom, if ever, start a conversation
with someone else, even if s/he might talk to
her/himself?
6. Marked impairment in the ability to initiate or
sustain a conversation with others, despite
adequate speech
(b) In individuals with adequate speech, marked
impairment in the ability to initiate or sustain a
conversation with others
C. THESE ARE QUESTIONS ABOUT SON/
DAUGHTER’ S ACTIVITIES OR INTERESTS
C. MARKEDLY RESTRICTED REPERTOIRE OF
ACTIVITIES AND INTERESTS
(3) RESTRICTED REPETITIVE AND
STEREOTYPED PATTERNS OF BEHAVIOR,
INTERESTS, AND ACTIVITIES
1. Did s/he ever have any repetitive patterns of
behavior such as hand movements, clapping or
twirling?
1. Stereotyped body movements, e.g., hand-
flicking or -twisting, spinning, head-banging,
complex whole-body movements
(c) Stereotyped and repetitive motor
mannerisms
2. Did s/he ever have any prolonged
attachments to certain objects, either holding
them or staring at them, or lining them up in a
repetitive pattern?
2. Persistent preoccupation with parts of objects
or attachment to unusual objects
(d) Persistent preoccupation with parts of
objects
3. Did s/he ever get unusually upset if there
were even small changes in where things were
placed in the house?
3. Marked distress over changes in trivial aspects
of environment
4. Or get upset when there are changes in daily
routine?
4. Unreasonable insistence on following routines
in precise detail
(b) Apparently inflexible adherence to
specific, nonfunctional routines or rituals
5. Does s/he have an extremely restricted range
of interests, or a preoccupation with one very
narrow interest
5. Markedly restricted range of interests and a
preoccupation with one narrow interest
(a) Encompassing preoccupation with one
or more stereotyped and restricted patterns
of interest that is abnormal either in
intensity or focus
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ASDs by this interview required a lifelong severe and
pervasive deficit in development of reciprocal social
interaction, communication, and restricted patterns of
behavior. ASD subjects were defined as subjects meeting
c r i t e r i af o ra u t i s t i cd i s o r d e ro rP D D - N O S .T ob eg i v e n
the diagnosis of autistic disorder, the participant had to
meet DSM-III-R diagnostic criteria of eight out of six-
teen symptoms with at least two symptoms from each
of the three aforementioned domains of PDD. A diagno-
sis of PDD-NOS was received if more than two of the
required symptoms were met with at least one symptom
present from each of the three domains of PDD. This
DSM-III-R based structured interview for ASD was
developed prior to the release of DSM-IV criterion for
ASD. This interview for ASD was administered to all
the participants in this study. As data collection for the
psychiatric comparison group in this study preceded the
advent of DSM-IV, in order to maintain consistency in
assessment the DSM-III-R criterion was retained beyond
the release of DSM-IV. This DSM-based structured
interview for ASD is added as a module to K-SADS-E
and is administered by the trained interviewer in similar
manner as the structured interview. All questions in the
structured interview are asked in yes/no format. If the
interviewee positively endorses a question, interviewers
have specific follow-up questions they are required to
ask. These questions include ages a symptom began/
ended, if such statements have been true in the past
month, and specific examples to elaborate on responses
to the initial probes. Responses to follow-up questions
help to determine whether each criterion is met. Sup-
porting the interrater reliabil i t yo ft h i sd i a g n o s t i ci n t e r -
view, the kappa coefficient of agreement for ASDs
between the raters and experienced board certified child
and adult psychiatrists and licensed clinical psycholo-
gists was 0.90. For ASDs, the reliability between an indi-
vidual clinician and the review committee assigned
diagnoses was 0.88. Table 1 also addresses the correla-
tion between DSM-III-R criteria and DSM-IV criteria
that clearly indicate that our DSM-based interview suffi-
ciently covers both versions of the DSM.
Full scale IQ
Subjects with ASDs were assessed with the WASI [15].
Psychiatric comparison subjects were assessed with the
WISC-R (N = 464) [16], WISC-3 (N = 97) [17], or the
WASI (N = 77) [15]. The study was approved by the
Institutional Review Board and in all cases parents gave
written informed consent for participation.
Statistical Approach
Conditional probabilities were calculated by determining
how many clinically diagnosed ASD subjects and psy-
chiatric comparison subjects met ASD criteria using the
structured interview ASD module. We also determined
how many ASD subjects had SRS scores of 60 or above.
Then we examined the relationship between the struc-
tured interview diagnosis of ASD and scores on the SRS
using two-sample t-tests. We randomly excluded 30% of
the females from the original pool of the psychiatric
comparison group so that both groups had similar gen-
der ratios.
Results
Out of 196 consecutive referrals to the program between
October 2007 and August 2009, 123 individuals met the
diagnostic criteria for ASD (75 autistic disorder, 22
Asperger’s disorder, and 26 PDD-NOS) on clinical eva-
luation by the expert clinician (GJ). The ADHD psychia-
tric comparison group (ADHD group, N = 1563) did
not significantly differ on age, sex, or ethnicity com-
pared to the ASD group (Table 2). The ASD group had,
on average, seven points lower full scale IQ compared
to the ADHD group (p < 0.001, Table 2).
Concurrent Validity
Ninety-four percent (116/123) of the clinically diagnosed
subjects with ASD also met criteria for ASD on the
DSM-based structured diagnostic interview for ASDs
resulting in a sensitivity of the DSM-based structured
diagnostic interview for ASDs of 94%. Ninety-five per-
cent (n = 117) of the clinically diagnosed subjects with
ASD had an SRS t-score of 60 or higher (in the clinical
range for ASD). Of the 116 subjects with a positive diag-
nosis of ASD on the DSM-based structured interview
for ASD, 112 (97%) also had an SRS t-score of 60 or
higher. Of the 117 subjects with an SRS t-score of 60 or
higher, 112 (96%) had a positive diagnosis of ASD on
the DSM-based structured interview diagnosis for ASD.
Figure 1 summarizes the 3-way agreement found
between clinical interview, the structured interview, and
the SRS.
Figure 2A shows the correspondence between the
DSM-based ASD structured interview diagnosis and the
SRS t-scores. The small number (n = 7) of subjects that
did not meet criteria for ASD on the DSM-based struc-
tured interview for ASD (but met criteria for ASD by
Table 2 Demographics and IQ scores
ASD (N =
123)
ADHD (N =
1563)
Test
Statistic
p-
value
Age 10.9 ± 4.3 10.3 ± 3.3 t(1684)=1.89 0.06
% Male 109 (87) 1305 (83) c
2
(1)=0.60 0.44
%
Caucasian
112 (89) 1198
a (93) c
2
(1)=2.57 0.11
Full Scale
IQ
96.7 ± 18.4
b 103.9 ± 15.1
c t(695)=3.38 <0.001
aout of N = 1284;
bN = 57;
cN = 640
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in the clinical range (t = 65.0, SD = 10.3) that was sig-
nificantly lower than the mean SRS t-score in subjects
with a structured diagnostic interview for ASDs corre-
sponding to PDD-NOS (t = 77.5, SD = 11.7) and sub-
jects with an ASD structured interview diagnosis of
autistic disorder (t = 83.8, SD = 7.8). As shown in Figure
2B, subjects diagnosed with autistic disorder had a sig-
nificantly higher rate of abnormal SRS scores compared
to the other two groups.
Discriminant Validity
Eleven percent (172/1563) of the ADHD group met
structured interview criteria for ASDs on the DSM-
based structured interview for ASDs. Therefore, a con-
servative estimate of the specificity of the DSM-based
structured interview for ASD was 89%. Positive predic-
tive value was 40% (116/288), and negative predictive
value was 99.8% (1391/1398). In the ADHD group,
subjects with a positive ASD diagnosis from the DSM-
based structured interview were significantly younger
than subjects without an ASD diagnosis (9.6 ± 3.5 ver-
sus 10.4 ± 3.3, z = -2.92, p = 0.003). Age was not sig-
nificantly associated with the DSM-based structured
interview diagnosis of ASD in the ASD group (z =
0.05, p = 0.96). In both of the groups, there was no
relationship between meeting criteria for a structured
interview diagnosis of ASDs and full scale IQ (ASD, z
= 0.60, p = 0.54; ADHD, z = 0.51, p = 0.61). In the
ASD group, subjects with a previous diagnosis of ASD
were significantly more likely to receive a structured
interview diagnosis of ASDs compared to subjects who
not been previously diagnosed with ASD (previously
diagnosed = 109/112, 97%; not previously diagnosed =
7/11, 64%; c2(1) = 21.18, p < 0.001). Likewise, the clin-
ician diagnosis was significantly associated with the
structured interview diagnosis of ASD (autism = 100%
received structured interview diagnosis of ASD; Asper-
ger’s disorder = 91%; PDD-NOS = 81%; c2(2) = 13.88,
p = 0.001).
Discussion
The main purpose of the present study has been to
evaluate the concurrent and discriminant validity of a
simplified DSM-based structured diagnostic interview
for the assessment of ASDs in a clinical setting. The
present study reports excellent agreement of the DSM-
based ASD structured diagnostic instrument with a
gold standard expert clinician diagnosis of ASD based
on a DSM-IV clinical assessment through detailed
interviews with the patient and the parent. Results also
showed excellent sensitivity and specificity when com-
parisons were made between subjects with ASD and
subjects with ADHD. These results indicate that our
DSM-based structured diagnostic interview for ASD
can be a useful and cost-effective standardized assess-
ment instrument for reliably identifying ASD in clinical
and research settings. Many clinics and research set-
tings employ diagnostic structured interviews for
screening a broad range of psychiatric disorders but
these structured interviews lack measures to evaluate
ASD. Therefore, this DSM based structured diagnostic
interview - that is administered in a similar manner as
structured interviews - would complement methods
Autism Spectrum Disorder 
Clinical Interview 
(N=123) 
Autism Spectrum Disorder 
Structured Interview  
Social Responsiveness Scale 
 (t-score ≥60) 
94%  
(116/123) 
95% 
(117/123) 
97% 
(112/116) 
96% 
(112/117) 
Figure 1 Summary of agreement between the clinical
interview, DSM-based autism spectrum structured interview,
and Social Responsiveness Scale.
Autism Spectrum Disorder 
Clinical Interview 
(N=123) 
Autism Spectrum Disorder 
Structured Interview  
Social Responsiveness Scale 
 (t-score ≥60) 
94%  
(116/123) 
95% 
(117/123) 
97% 
(112/116) 
96% 
(112/117) 
Figure 2 A. Mean Social Responsiveness Scale (SRS) t-scores by structured interview autism spectrum disorder (ASD) diagnosis.B .
Percent with abnormal (≥ 60) Social Responsiveness Scale (SRS) t-scores by structured interview autism spectrum disorder (ASD) diagnosis.
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diagnostic interviews. This may improve the efficiency
of the assessment, as it is included with screening of
other psychiatric conditions.
Our design provides a reasonable estimate of sensitiv-
ity (i.e., the probability of our structured interview cor-
rectly identifying ASD cases). Remarkably, the sensitivity
of the structured interview was extremely high, 94%.
Equally remarkable is the finding of a 95% sensitivity of
an SRS t-score of 60 or higher (accepted cut-off for a
screen of ASD) as an indicator of the gold standard
diagnosis. Consistent with these findings, 97% of sub-
jects with our DSM based structured interview diagnosis
of ASD also had an SRS t-score in the clinical range (≥
60). If replicated, these findings would support the uti-
lity of a simple to use structured diagnostic instrument
based on the defining items for ASD in the DSM-IV to
help identify youth with ASD.
Results from our analysis show that the correspon-
dence between our DSM-based structured interview for
ASD with the expert clinician assessment was unrelated
to the IQ of the subjects in both clinical samples. In
addition, our structured interview allowed for the diag-
nosis of subjects with subthreshold disorders and differ-
ent definitions of ASDs such as Asperger’sD i s o r d e ro r
PDD-NOS, where the ADI-R algorithm score for social
impairment may fall below the published clinical cutoff.
Thus, our DSM-based structured interview for ASD
may be useful and accurate for the assessment of ASD
individuals across different cognitive and developmental
levels with full and subsyndromal manifestations of
these disorders.
Our results must be interpreted in the context of
some methodological limitations. Since subjects in this
study were referred for ASDs, our results may not gen-
eralize to other clinical and non-clinical settings.
Because our sample consisted largely of Caucasian sub-
jects, we do not know whether our results will general-
ize to other ethnic groups. The SRS is validated for
youth ages 4 to 18 years but 4% (5/123) of our ASD
sample was older than 18 years and received the scale.
Although our DSM-based structured interview for ASD
was DSM-III-R based, there have been very few changes
between the DSM-III-R definitions of ASD and those in
DSM-IV (see Table 1). Moreover, we documented a
very high correspondence between the DSM-IV based
clinician diagnosis of ASD and this instrument. Just as
the current version of the structured interview is able to
capture both DSM-III-R and DSM-IV diagnostic criteria,
a revised version will capture DSM-V measures. As cur-
rently proposed, DSM-V criteria for Autism Spectrum
Disorders are more narrow and unidimentional. As
such, the DSM-based structured interview presented in
this paper incorporates the criteria proposed in DSM-V.
Coding criteria could also be altered in the future to
encompass the changes proposed in the diagnostic cri-
teria for ASD in DSM-V.
Conclusions
Despite these considerations, our results document the
utility of a DSM-based, simple to use and administer,
relatively brief structured diagnostic instrument to aid in
the identification of youth with ASDs in the clinical set-
ting. If confirmed, these findings would suggest that our
DSM-based structured diagnostic instrument for ASD
could serve as a rapid and cost-effective assessment
instrument to help identify cases likely to meet clinical
criteria for ASDs in clinical and non-clinical settings.
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